Carl read the papersWhat it actually is
BPC-157 is a synthetic peptide based on a naturally-occurring sequence found in human gastric juice — the “Body Protection Compound.” Researchers isolated the active fragment and it’s been studied for decades, mostly in rats, for helping damaged tissue knit back together.
It’s stable in the stomach (unusual for a peptide), which is why it appears in both injectable and oral research forms. Despite a large animal-research base, human clinical trials are very few.
How it’s thought to work
- Angiogenesis — promotes new blood-vessel growth (via the VEGFR2 pathway), bringing blood flow to injured tissue.
- Fibroblast migration — helps the cells that build tendons and ligaments move to where they’re needed.
- Gut protection — shields and repairs the GI lining, which is where its story started.
- Growth-factor signaling — modulates nitric-oxide and growth-factor pathways tied to healing.
What the research says
Honest version: strong in animals, sparse in humans. Rodent studies repeatedly show accelerated healing of Achilles tendon, muscle, ligament and gut injuries. Human evidence is largely anecdotal plus three tiny uncontrolled studies (30 people in total, per a 2026 review). Placebo-controlled trials are now registered but have not reported.
- Tendon & ligament repair — the most-cited use case.
- Gastrointestinal healing — ulcers, IBD models, leaky-gut research.
- Reported post-injury recovery in the community (anecdotal).
Watch: BPC-157 explained
Video by Talking With Docs on YouTube. Not affiliated with Peptide Carl and not an endorsement — included because a second explanation of the same mechanism is often what makes it click.
Reported protocols
These are the doses the peptide community actually reports running (Reddit & forums), alongside published research — logged for education, not as a recommendation to use.
| Parameter | Commonly reported range |
|---|---|
| Community dose | 250–500 mcg/day (250 mild/prophylactic; 500 acute, split AM/PM) |
| Frequency | 1–2× daily |
| Route | SubQ for muscle/tendon; oral for gut/IBD |
| Cycle | 4–8 weeks, then break & repeat |
| Community tip | Pin subQ near the injury; rotate 6–8 sites or you get nodules; classic TB-500 stack |
Common use cases
| Goal | Community protocol notes |
|---|---|
| Tendon / ligament repair | 250–500 mcg/day subQ near injury, 4–6 wks |
| Gut healing (IBS / leaky gut) | 250–500 mcg/day oral, 4–8 wks |
| Post-surgery recovery | 300–500 mcg/day subQ from post-op, 4–6 wks |
Mixing it (reconstitution)
Freeze-dried peptides must be reconstituted with bacteriostatic water before they can be measured. Carl’s calculator turns “mg in the vial + ml of water + target dose” into “units on the syringe” — and tells you how long the vial lasts.
→ Open the Reconstitution Calculator
Injection & handling
SubQ (or oral for gut goals), 250–500 mcg daily — inject subQ near the injury when practical (knee fat pad, near a shoulder; lower abdomen for systemic/gut). Rotate 6–8 sites to avoid nodules. Refrigerate reconstituted, use within ~28 days.
Stacks it appears in
- The Wolverine — BPC-157 + TB-500 — the classic recovery pairing. The one rat study of the pair (2026) found no extra benefit over either alone.
- The Reset — Semaglutide + BPC-157, tried in the community to ease GLP-1 stomach side-effects. Never studied together.
Sources
- BPC 157 in the gut, review by its developers, Curr Pharm Des 2011 (PMID 21548867)
- Rat Achilles tendon healing, J Orthop Res 2003 (PMID 14554208)
- Rat ligament healing, J Orthop Res 2010 (PMID 20225319)
- Rat quadriceps muscle healing, J Orthop Res 2006 (PMID 16609979)
- Angiogenesis via VEGFR2, J Mol Med 2017 (PMID 27847966)
- Tendon fibroblast outgrowth and migration, J Appl Physiol 2011 (PMID 21030672)
- BPC 157 and the nitric-oxide system, Curr Pharm Des 2014 (PMID 23755725)
- Pharmacokinetics in rats and dogs, Front Pharmacol 2022 (PMID 36588717)
- Systematic review of human evidence, Acta Orthop Belg 2026 (PMID 42885452)
- Phase 2 placebo-controlled hamstring trial (NCT07437547)
- BPC-157 plus TB-500 in rat Achilles repair, Jt Dis Relat Surg 2026 (PMID 42542926)
- WADA 2026 Prohibited List
